Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
CLEC2D
Introduction
C-type lectin domain family 2 member D is a protein that in humans is encoded by the CLEC2D gene.[1]
This gene encodes a member of the natural killer cell receptor C-type lectin family. The encoded protein inhibits osteoclast formation and contains a transmembrane domain near the N-terminus as well as the C-type lectin-like extracellular domain. Several alternatively spliced transcript variants have been identified, but the full-length nature of every transcript has not been defined.[1] CLEC2D encodes the gene for the Lectin Like Transcript-1 (LLT1) protein which is a functional ligand for the human NKR-P1A receptor, encoded by the KLRB1 gene. In mice, there are many orthologs of the CLEC2D gene, and the presumed homolog is Clr-b/Ocil (Clec2d). Clr-b has been implicated in missing-self recognition by natural killer cells through engagement of the NKR-P1B receptor.
External links
External links
- Human CLEC2D genome location and CLEC2D gene details page in the UCSC Genome Browser.
Further reading
Further reading
- Boles KS, Barten R, Kumaresan PR, et al. (1999). “Cloning of a new lectin-like receptor expressed on human NK cells”. Immunogenetics. 50 (1–2): 1–7. doi:10.1007/s002510050679. PMID 10541800.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Iizuka K, Naidenko OV, Plougastel BF, et al. (2003). “Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors”. Nat. Immunol. 4 (8): 801–7. doi:10.1038/ni954. PMID 12858173.
- Hu YS, Zhou H, Myers D, et al. (2004). “Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts”. J. Bone Miner. Res. 19 (1): 89–99. doi:10.1359/JBMR.0301215. PMID 14753741.
- Carlyle JR, Jamieson AM, Gasser S, et al. (2004). “Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors”. Proc. Natl. Acad. Sci. U.S.A. 101 (10): 3527–32. doi:10.1073/pnas.0308304101. PMC 373496. PMID 14990792.
- Mathew PA, Chuang SS, Vaidya SV, et al. (2004). “The LLT1 receptor induces IFN-gamma production by human natural killer cells”. Mol. Immunol. 40 (16): 1157–63. doi:10.1016/j.molimm.2003.11.024. PMID 15104121.
- Gange CT, Quinn JM, Zhou H, et al. (2004). “Characterization of sugar binding by osteoclast inhibitory lectin”. J. Biol. Chem. 279 (28): 29043–9. doi:10.1074/jbc.M312518200. PMID 15123656.
- Aldemir H, Prod’homme V, Dumaurier MJ, et al. (2006). “Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor”. J. Immunol. 175 (12): 7791–5. doi:10.4049/jimmunol.175.12.7791. PMID 16339512.
- Rosen DB, Bettadapura J, Alsharifi M, et al. (2006). “Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor”. J. Immunol. 175 (12): 7796–9. doi:10.4049/jimmunol.175.12.7796. PMID 16339513.
- Rosen DB, Cao W, et al. (2008). “Functional Consequences of Interactions between Human NKR-P1A and Its Ligand LLT1 Expressed on Activated Dendritic Cells and B Cells”. J. Immunol. 180 (10): 6508–6517. doi:10.4049/jimmunol.180.10.6508. PMC 2577150. PMID 18453569.